Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02732041
Other study ID # CEMIC1008
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 25, 2016
Est. completion date February 2019

Study information

Verified date January 2020
Source Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Asynchrony during mechanical ventilation has been poorly described in patients suffering from acute respiratory distress syndrome. The purpose of this study is to describe the frequency of asynchronies (ineffective efforts and double triggering) in these group and evaluate potential risk factors and prognosis implications.


Description:

Major patient-ventilator asynchronies have been described during assisted mechanical ventilation in different settings. Few studies have evaluated double cycling in ARDS patient. No clear predictors of this finding beside low tidal volume have been found, and clinical outcome implications have not been addressed. This study has 3 main objectives: evaluate the frequency of double cycling and ineffective efforts, seek for potential predictors and clinical outcomes related to asynchronies. Subjects with less than 72 hours of mechanical ventilation due to ARDS will be recruited. Thirty minutes of mechanical ventilation will be recorded and automatically analyzed with a custom-made program to detect asynchronies. A blood sample will be drawn to measure inflammatory and lung tissue damage biomarkers. Clinical and outcome data will be recorded.


Recruitment information / eligibility

Status Completed
Enrollment 103
Est. completion date February 2019
Est. primary completion date November 22, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria:

- Acute Respiratory Distress Syndrome according to Berlin definition

- Intubation and mechanical ventilation within 72 hours of inclusion

Exclusion Criteria:

- Known severe neuromuscular disease

- Continuous neuromuscular blocking agents infusion

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Argentina CEMIC (Centro de Educación Médica e Investigaciones Clínicas) Caba
Argentina Complejo Medico Churruca Visca Ciudad Autonoma Buenos Aires Buenos Aires
Argentina Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires Buenos Aires
Argentina Sanatorio Anchorena Ciudad Autonoma Buenos Aires Buenos Aires
Argentina Sanatorio La Trinidad Mitre Ciudad Autonoma Buenos Aires Buenos Aires

Sponsors (1)

Lead Sponsor Collaborator
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno

Country where clinical trial is conducted

Argentina, 

Outcome

Type Measure Description Time frame Safety issue
Primary Asynchrony rate Asynchronies per minutes of mechanical ventilation 30 minutes
Secondary Length of mechanical ventilation From the date of intubation to the date of complete weaning from mechanical ventilation or death which ever comes first, up to 90 days
Secondary ICU mortality From the date of admission to the date of discharge from the ICU, up to 90 days
Secondary Hospital mortality From the date of admission to the date of discharge from the ICU, up to 90 days
See also
  Status Clinical Trial Phase
Completed NCT03712215 - STUDY OF ELECTRICAL STIMULATION IN PULMONARY FUNCTION IN INTENSIVE CARE UNIT N/A
Completed NCT04582201 - Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2 Phase 1/Phase 2
Recruiting NCT01990456 - Strategies for Optimal Lung Ventilation in ECMO for ARDS: The SOLVE ARDS Study N/A
Completed NCT01167621 - Changes in Refractory Acute Respiratory Distress Syndrome (ARDS) Patients Under High Frequency Oscillation-ventilation N/A
Terminated NCT00233207 - IC14 Antibodies to Treat Individuals With Acute Lung Injury Phase 2
Completed NCT00029328 - Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation Phase 1/Phase 2
Completed NCT00004494 - Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis Phase 1
Completed NCT00000579 - Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) Phase 3
Recruiting NCT03236272 - Establishment of a Biomarkers-based Early Warning System of Acute Respiratory Distress Syndrome (ARDS)
Withdrawn NCT04508933 - Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS Patients
Completed NCT02273687 - Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in Emergency Department N/A
Recruiting NCT03424798 - Measuring Heart and Lung Function in Critical Care N/A
Recruiting NCT01992237 - Measuring Energy Expenditure in ECMO (Extracorporeal Membrane Oxygenation) Patients N/A
Completed NCT00719446 - Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials N/A
Completed NCT00236262 - Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory Distress Syndrome N/A
Completed NCT00300248 - Long-Term Results in Mechanically Ventilated Individuals With Acute Lung Injury/Acute Respiratory Distress Syndrome N/A
Completed NCT00157144 - Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005 N/A
Completed NCT00141726 - Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant Phase 2
Recruiting NCT00465374 - A Validation/Interventional Study on Stress Index in Predicting Mechanical Stress in ARDS Patients Phase 3
Completed NCT00094406 - Carbon Monoxide to Prevent Lung Inflammation Phase 1